Matches in SemOpenAlex for { <https://semopenalex.org/work/W4246955446> ?p ?o ?g. }
Showing items 1 to 80 of
80
with 100 items per page.
- W4246955446 endingPage "469" @default.
- W4246955446 startingPage "463" @default.
- W4246955446 abstract "Objective: Zidovudine (ZDV) is the only antiretroviral drug which has been shown to reduce mortality in patients with symptomatic HIV disease, but its use is restricted by intolerance in a significant proportion of patients. Additionally, the efficacy of ZDV therapy appears to decrease after prolonged treatment particularly in the advanced stage of HIV disease. Therefore, alternative antiretroviral regimens for patients are needed. In this study, didanosine (ddl; 2′,3′-dideoxyinosine), another HIV reverse transcriptase inhibitor, was evaluated. Design: A total of 426 patients with AIDS or AIDS-related complex (ARC) who were intolerant to or clinically progressing on ZDV therapy and who had CD4+ cell counts ≤ 150 × 106/l were randomized to receive either a high (750 mg for bodyweight ≥ 60 kg or 500 mg for bodyweight < 60 kg) or a low (200 mg and 1 34 mg, respectively) dose of ddl daily. Setting: The patients were recruited from 31 German and Austrian AIDS clinical primary-care centres. Results: The study was stopped after the second interim analysis due to a statistically significant difference in the incidence of pancreatitis (nine versus 26; relative risk, 2.92; P = 0.003) and neuropathy (28 versus 43; relative risk, 1.55; P = 0.05) in favour of the low dose. There was no difference between the low and high dosage groups in survival rate at 6 (80 versus 80%) and 12 months (61 versus 65%), number of deaths [82 (43.6 per 100 patient-years) versus 84 (44.4 per 100 patient-years)], progression from ARC to AIDS or to AIDS or death, or average number of new/recurrent opportunistic infections (2.8 versus 3.0 per patient). Conclusions: This study cannot conclude on ddl efficacy but it shows that in patients with advanced HIV disease for whom no alternative antiretroviral therapy is available and ddl therapy is considered, daily doses < 750 mg should be administered. AIDS 1995, 9:463-469" @default.
- W4246955446 created "2022-05-12" @default.
- W4246955446 creator A5002857469 @default.
- W4246955446 creator A5009574331 @default.
- W4246955446 creator A5010086618 @default.
- W4246955446 creator A5016506837 @default.
- W4246955446 creator A5019755529 @default.
- W4246955446 creator A5031405171 @default.
- W4246955446 creator A5034385602 @default.
- W4246955446 creator A5062597085 @default.
- W4246955446 creator A5066949455 @default.
- W4246955446 creator A5077428594 @default.
- W4246955446 creator A5083339355 @default.
- W4246955446 creator A5089221765 @default.
- W4246955446 date "1995-05-01" @default.
- W4246955446 modified "2023-10-18" @default.
- W4246955446 title "A dose comparison study of didanosine in patients with very advanced HIV infection who are intolerant to or clinically deteriorate on zidovudine" @default.
- W4246955446 doi "https://doi.org/10.1097/00002030-199509050-00008" @default.
- W4246955446 hasPublicationYear "1995" @default.
- W4246955446 type Work @default.
- W4246955446 citedByCount "8" @default.
- W4246955446 crossrefType "journal-article" @default.
- W4246955446 hasAuthorship W4246955446A5002857469 @default.
- W4246955446 hasAuthorship W4246955446A5009574331 @default.
- W4246955446 hasAuthorship W4246955446A5010086618 @default.
- W4246955446 hasAuthorship W4246955446A5016506837 @default.
- W4246955446 hasAuthorship W4246955446A5019755529 @default.
- W4246955446 hasAuthorship W4246955446A5031405171 @default.
- W4246955446 hasAuthorship W4246955446A5034385602 @default.
- W4246955446 hasAuthorship W4246955446A5062597085 @default.
- W4246955446 hasAuthorship W4246955446A5066949455 @default.
- W4246955446 hasAuthorship W4246955446A5077428594 @default.
- W4246955446 hasAuthorship W4246955446A5083339355 @default.
- W4246955446 hasAuthorship W4246955446A5089221765 @default.
- W4246955446 hasConcept C126322002 @default.
- W4246955446 hasConcept C141071460 @default.
- W4246955446 hasConcept C203014093 @default.
- W4246955446 hasConcept C2776452011 @default.
- W4246955446 hasConcept C2777351918 @default.
- W4246955446 hasConcept C2777447569 @default.
- W4246955446 hasConcept C2779127605 @default.
- W4246955446 hasConcept C2779889181 @default.
- W4246955446 hasConcept C2780216070 @default.
- W4246955446 hasConcept C2780727368 @default.
- W4246955446 hasConcept C3013748606 @default.
- W4246955446 hasConcept C71924100 @default.
- W4246955446 hasConcept C90924648 @default.
- W4246955446 hasConceptScore W4246955446C126322002 @default.
- W4246955446 hasConceptScore W4246955446C141071460 @default.
- W4246955446 hasConceptScore W4246955446C203014093 @default.
- W4246955446 hasConceptScore W4246955446C2776452011 @default.
- W4246955446 hasConceptScore W4246955446C2777351918 @default.
- W4246955446 hasConceptScore W4246955446C2777447569 @default.
- W4246955446 hasConceptScore W4246955446C2779127605 @default.
- W4246955446 hasConceptScore W4246955446C2779889181 @default.
- W4246955446 hasConceptScore W4246955446C2780216070 @default.
- W4246955446 hasConceptScore W4246955446C2780727368 @default.
- W4246955446 hasConceptScore W4246955446C3013748606 @default.
- W4246955446 hasConceptScore W4246955446C71924100 @default.
- W4246955446 hasConceptScore W4246955446C90924648 @default.
- W4246955446 hasIssue "5" @default.
- W4246955446 hasLocation W42469554461 @default.
- W4246955446 hasOpenAccess W4246955446 @default.
- W4246955446 hasPrimaryLocation W42469554461 @default.
- W4246955446 hasRelatedWork W1973454901 @default.
- W4246955446 hasRelatedWork W1984270093 @default.
- W4246955446 hasRelatedWork W1997931264 @default.
- W4246955446 hasRelatedWork W2009155779 @default.
- W4246955446 hasRelatedWork W2041480391 @default.
- W4246955446 hasRelatedWork W2166150294 @default.
- W4246955446 hasRelatedWork W2326530258 @default.
- W4246955446 hasRelatedWork W2418276897 @default.
- W4246955446 hasRelatedWork W2736657145 @default.
- W4246955446 hasRelatedWork W283351130 @default.
- W4246955446 hasVolume "9" @default.
- W4246955446 isParatext "false" @default.
- W4246955446 isRetracted "false" @default.
- W4246955446 workType "article" @default.